(13) as IKZF1 deletion accompanied by at least one gene deletion in CDKN2A/B, PAX5, PAR1 in the absence of ERG deletion in pediatric B-ALL. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.